CIPROFLOXACIN TABLETS
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency, under the Department of Defense, issued award SPE2DP26F9051 to DMS Pharmaceutical Group Inc. for the procurement of Ciprofloxacin tablets. This delivery order, valued at 104,830.00 dollars, was placed on August 19, 2026, and requires the delivery of 250 bottles of the medication by September 3, 2026. The order is categorized under NAICS code 424210 and is associated with National Stock Number 6505013334154. This specific award is a delivery order issued under the broader base contract SPE2DX25D9900, which was established on April 2, 2025, with a total award value of 19,999,999.00 dollars. The base contract was managed by the DLA Troop Support Medical Supply Chain FSB and serves as the overarching agreement for the supply of medical goods, replacing previous contract SPE2DX25D9383.
General Info
Contract Value
$104,830Place of Performance
Not specifiedSet-Aside
Awardee
DMS PHARMACEUTICAL GROUP INCAward Issued Date
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
